Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VKA”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableStudy completedNCT02090543
What this trial is testing

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies

Who this might be right for
Atrial Fibrillation
Bayer 647
Large-scale testing (Phase 3)Study completedNCT02942576
What this trial is testing

Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 632
Post-approval studies (Phase 4)Study completedNCT01727453
What this trial is testing

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.

Who this might be right for
Acute Gastrointestinal Bleeding
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 40
Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Who this might be right for
Atrial Fibrillation
Bayer 1,504
Not applicableUnknownNCT04462614
What this trial is testing

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

Who this might be right for
Chronic HemolysisVKAAnticoagulants / Administration & Dosage+7 more
CHU de Reims 49
Not applicableStudy completedNCT03826927
What this trial is testing

New Oral Anticoagulants (NOAC) in Stroke Patients

Who this might be right for
StrokeAtrial Fibrillation
University Hospital, Basel, Switzerland 1,023
Testing effectiveness (Phase 2)Study completedNCT00623779
What this trial is testing

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Who this might be right for
Persistent or Permanent Non-valvular Atrial Fibrillation
AstraZeneca 128
Testing effectiveness (Phase 2)Study completedNCT05205863
What this trial is testing

Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation

Who this might be right for
Healthy Volunteers
Prothya Biosolutions 69
Not applicableStudy completedNCT02657616
What this trial is testing

Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA

Who this might be right for
Atrial FibrillationStroke Prophylaxis
Institut für Pharmakoökonomie und Arzneimittellogistik e.V. 204,464
Not applicableStudy completedNCT02240667
What this trial is testing

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,506
Not applicableNot Yet RecruitingNCT07570511
What this trial is testing

Point of Care Testing INR in Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeVitamine K Antagonist (VKA) Treatment
Central Hospital, Nancy, France 150
Large-scale testing (Phase 3)Study completedNCT00062803
What this trial is testing

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Sanofi
Not applicableStudy completedNCT03532724
What this trial is testing

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

Who this might be right for
Self Management of Oral Anticoagulation With VKA Therapy
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 927
Not applicableStudy completedNCT02843958
What this trial is testing

Validation of a Portable Medical Device for Diagnostic in Vitro

Who this might be right for
Healthy VolunteerPatients Under Vitamin K Antagonist (VKA)
University Hospital, Grenoble 40
Not applicableStudy completedNCT03462446
What this trial is testing

Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

Who this might be right for
Atrial Fibrillation
Bayer 249
Not applicableNot Yet RecruitingNCT06884384
What this trial is testing

DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study

Who this might be right for
Antiphospholipid Syndrome (APS)Cohort StudyThrombotic and Bleeding Events
Central Hospital, Nancy, France 310
Testing effectiveness (Phase 2)Study completedNCT01533441
What this trial is testing

Vitamin K2 Intervention in Patients With Vitamin K Antagonists

Who this might be right for
Thrombosis
Danisco 50
Testing effectiveness (Phase 2)Study completedNCT02981472
What this trial is testing

The Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Who this might be right for
Thrombosis
Bristol-Myers Squibb 192
Not applicableStudy completedNCT02687854
What this trial is testing

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 18,591
Not applicableStudy completedNCT02596230
What this trial is testing

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 7,797
Next Page